Literature DB >> 32332201

Infodemic and the spread of fake news in the COVID-19-era.

Daniele Orso1,2, Nicola Federici1,2, Roberto Copetti3, Luigi Vetrugno1,2, Tiziana Bove1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32332201      PMCID: PMC7202120          DOI: 10.1097/MEJ.0000000000000713

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


× No keyword cloud information.
Saturday 14 March, while the pandemic due to SARS-CoV-2 spread widely in Europe, the French Minister of Health, Oliver Véran tweeted: ‘The intake of anti-inflammatory drugs (ibuprofen, cortisone, …) could be a factor in worsening the infection. If you have a fever, take acetaminophen. If you are already taking anti-inflammatory drugs or in doubt, ask your doctor for advice’ [1]. As the hours go by, the tweet garnered the consent of more and more ‘followers’, and, 3 days later, the ‘re-tweets’ were over 40 000. The University Hospital of Vaud in Lausanne – among others – considered the news as authentic and correct, so claims: ‘For the current state of knowledge, the use of anti-inflammatory drugs (ibuprofen, ketoprofen, naproxen, diclofenac, etc.) is not recommended in case of influenza-like illness possibly caused by COVID-19. Paracetamol is recommended in the event of fever requiring treatment’. In the transmission of the news, one of the ‘accused’ classes of drugs was exonerated (e.g. any reference to cortisone disappeared). At the same time, the preference given to paracetamol became quite a strong recommendation [2]. The British Medical Journal also felt compelled to relaunch the news, reporting some expert opinions on this matter [3]. In the following days, we looked for news in the most popular biomedical libraries. If the report had been real, we would have had to find at least one article from some researchers who studied this issue. To our surprise, the search result offered us no documents. The only somewhat related articles dealt with antiviral drugs with anti-inflammatory properties [4] or showed increased survival in patients with COVID-19-related acute respiratory distress syndrome treated with methylprednisolone [5]. Still, our Facebook contacts, mostly non-doctors, continued to report the information. They tried to warn us not to use those drugs and to notify all their contacts as well. Their action seemed animated by a spirit of solidarity. So what was bothering us? When we spoke to one of our nurse colleagues, she asked: ‘So should I tell my father to stop taking cardioaspirin?’. Our friends, without realizing it and, indeed, trying to make the right action, were spreading potentially devastating news [6]. In the same weeks, we received discordant warnings about the use of ACE-inhibitors and sartans: now that they could have aggravated a possible COVID-19, now that they could have alleviated the symptoms. The media ‘tam-tam’ was so pounding that the European Society of Cardiology felt compelled to intervene to try to limit the individual stances [7]. But are these fake news? In technical terms, no. They come from sources believed to be reliable, and there is no reason to doubt their ‘authenticity’. They are not words fictitiously attributed to someone. However, in most cases, they are real but inaccurate news [8]. At the beginning of the pandemic, many of our colleagues said that it would not have been a very different situation from seasonal flu. They were wrong. While non-expert people, since the beginning, spread alarmed and frightened messages, getting closer to the truth than the experts. What is the cause of this ‘blindness’? We, physicians, push ourselves often in challenging assessments when we have very little data, and we are often ‘over-confident’ in our expertise. In our daily clinical activity, we continuously rely on our ability to ‘be convincing’ the others, even if we have insufficient data, and the degree of uncertainty is very high. Our ability is based on the fact that our patients have to trust us. However, our strength does not always allow us to see the data properly. In the next weeks, our Whatsapp chats and private mailboxes were overwhelmed by an avalanche of information, many of which were correct and authentic, but most were unusable. Although we realized that the new information led more to an increase in the entropy of the system rather than an increase in our knowledge, we also made ourselves accomplice in this self-blinding mechanism. Each of our re-tweets, each of our articles shared in a public chat increases the background noise. While potentially, our information may increase the signal, it is most likely only reducing the signal-to-noise ratio. The diffusion of social media has opened up an exciting field, capable, at least potentially, of increasing the degree of clarity and democracy in sharing scientific data. In the same way, it has dramatically increased the degree of credibility of personal opinions (beliefs, considerations, etc.) and allowed them to spread more rapidly. All of this is the opposite of democracy: opinion, contrary to facts, is always of the most influential people. The sharing of scientific data has two critical aspects: the presence or absence of ‘filters’ capable of increasing the reliability of the information [9]; and individual responsibility for making information public and disseminating [10]. Both aspects should be considered very seriously by every member of the scientific community.

Acknowledgements

Conflicts of interest L.V. received travel support from Cook Medical Inc. For the remaining authors, there are no conflicts of interest.
  59 in total

1.  Outbreak of Coronavirus Disease 2019 (COVID‑19) in Pakistan: Psychological impact and coping strategies of Health Care Professionals.

Authors:  Khola Noreen; Muhammad Umar; Syed Arshad Sabir; Rehana Rehman
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

Review 2.  Mis-Dis Information in COVID-19 Health Crisis: A Narrative Review.

Authors:  Vicente Javier Clemente-Suárez; Eduardo Navarro-Jiménez; Juan Antonio Simón-Sanjurjo; Ana Isabel Beltran-Velasco; Carmen Cecilia Laborde-Cárdenas; Juan Camilo Benitez-Agudelo; Álvaro Bustamante-Sánchez; José Francisco Tornero-Aguilera
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

3.  COVID-Lung: The Battlefield.

Authors:  Benan Bayrakci
Journal:  J Pediatr Intensive Care       Date:  2020-09-21

Review 4.  Pandemics and marketing: insights, impacts, and research opportunities.

Authors:  Gopal Das; Shailendra Pratap Jain; Durairaj Maheswaran; Rebecca J Slotegraaf; Raji Srinivasan
Journal:  J Acad Mark Sci       Date:  2021-05-12

5.  Fears Related to COVID-19 among Rural Older People in Japan.

Authors:  Ryuichi Ohta; Yoshinori Ryu; Chiaki Sano
Journal:  Healthcare (Basel)       Date:  2021-04-29

6.  Psychosocial factors and hospitalisations for COVID-19: Prospective cohort study of the general population.

Authors:  George David Batty; Ian Deary; Michelle Luciano; Drew Altschul; Mika Kivimaki; Catharine Gale
Journal:  medRxiv       Date:  2020-06-01

7.  Perception of COVID-19 Prevention Methods Efficacy and Intention to Use Among Patients with Chronic Disease in Dessie Town, Northeast Ethiopia: A Multicentered Cross-sectional Study.

Authors:  Abebe Dires; Sisay Gedamu; Yemiamrew Getachew
Journal:  J Multidiscip Healthc       Date:  2021-06-04

8.  Mental health, compliance with measures and health prospects during the COVID-19 epidemic: the role of health literacy.

Authors:  Lize Hermans; Stephan Van den Broucke; Lydia Gisle; Stefaan Demarest; Rana Charafeddine
Journal:  BMC Public Health       Date:  2021-07-10       Impact factor: 3.295

9.  The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.

Authors:  Marco Tuccori; Irma Convertino; Sara Ferraro; Emiliano Cappello; Giulia Valdiserra; Daniele Focosi; Corrado Blandizzi
Journal:  Drug Saf       Date:  2020-08       Impact factor: 5.228

10.  The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey.

Authors:  Sarra Boukhobza; Valentin Ritschl; Tanja Stamm; Katrin Bekes
Journal:  J Multidiscip Healthc       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.